Masimo Corp

Common Name

Masimo

Country

United States

Sector

Healthcare

Industry

Medical Devices

Employees

3,600

Ticker

MASI

Exchange

NASDAQ/NGS

Website

www.masimo.com

Description

Masimo Corporation is a global leader in noninvasive monitoring technologies, specifically focusing on developing innovative medical devices that improve patient outcomes and reduce the cost of care. ... Show more

Financial Statements of Masimo

Below are the financial statements of Masimo, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Income Statement (as reported) Balance Sheet (as reported)

All figures in millions of USD	2024	2023
Current assets	—	—
Cash and cash equivalents	177.6^a	163^a
Trade accounts receivable, net	411.3^a	348.2^a
Related party receivables	15.2^a	7.3^a
Inventories	459.2^a	545^a
Asset held for sale	17.4^a	0^a
Other current assets	145.1^a	168.4^a
Total current assets	1,225.8^a	1,231.9^a
Assets	—	—
Lease receivable, non-current	58.7^a	71.4^a
Deferred costs and other contract assets	61^a	57.3^a
Property and equipment, net	381.6^a	424.4^a
Customer relationships, net	157.6^a	177.7^a
Acquired technologies, net	102.9^a	129.4^a
Other intangible assets, net	90.4^a	112.8^a
Trademarks	207.3^a	232.4^a
Goodwill	96.7^a	407.7^a
Deferred tax assets	143.6^a	107.2^a
Other non-current assets	100.1^a	89.3^a
Total assets	2,625.7^a	3,041.5^a
Current liabilities	—	—
Accounts payable	252.8^a	251.5^a
Accrued compensation	83.6^a	62.6^a
Deferred revenue and other contract-related liabilities, current	95.5^a	87.3^a
Other current liabilities	185.8^a	162.4^a
Total current liabilities	617.7^a	563.8^a
Liabilities and equity	—	—
Long-term debt	727.9^a	871.7^a
Deferred tax liabilities	100.1^a	111.7^a
Other non-current liabilities	128.1^a	129.5^a
Total liabilities	1,573.8^a	1,676.7^a
Stockholders’ equity	—	—
Preferred stock	0^a	0^a
Common stock	0.1^a	0.1^a
Treasury stock	-1,169.2^a	-1,169.2^a
Additional paid-in capital	838.3^a	783.4^a
Accumulated other comprehensive loss	-108.2^a	-45.3^a
Retained earnings	1,490.9^a	1,795.8^a
Total stockholders’ equity	1,051.9^a	1,364.8^a
Total liabilities and stockholders’ equity	2,625.7^a	3,041.5^a

Verified Sources Behind Masimo’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Masimo’s data sources below and access millions more through our Disclosure Search.

a. Masimo's 10-K 2024

Trace every data point back to Masimo’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

Masimo Corp

Financial Statements of Masimo

Verified Sources Behind Masimo’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Dexcom Inc

Globus Medical Inc

Haemonetics Corp

Bio Rad Laboratories Inc

Procept Biorobotics Corp

Penumbra Inc